|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-1-6
|
|
pubmed:abstractText |
Nonseminomatous germ cell cancers (NSGCC) have a varied response to chemotherapy, some melting away with resultant cure, some have tumour stem cell necrosis and residual benign disease whilst others are resistant to treatment. The latter two require surgical excision in order to identify those needing high intensity chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0042-1138
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
61
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
22-6
|
|
pubmed:dateRevised |
2006-10-30
|
|
pubmed:meshHeading |
pubmed-meshheading:9792978-Adult,
pubmed-meshheading:9792978-Combined Modality Therapy,
pubmed-meshheading:9792978-Humans,
pubmed-meshheading:9792978-Male,
pubmed-meshheading:9792978-Neoplasm Metastasis,
pubmed-meshheading:9792978-Neoplasms, Germ Cell and Embryonal,
pubmed-meshheading:9792978-Predictive Value of Tests,
pubmed-meshheading:9792978-Prospective Studies,
pubmed-meshheading:9792978-Testicular Neoplasms,
pubmed-meshheading:9792978-Tomography, X-Ray Computed
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Potential of limited day 21 post-chemotherapy CT scan in predicting need for post-chemotherapy surgery in nonseminomatous testicular germ cell cancer.
|
|
pubmed:affiliation |
Department of Medical Imaging, The Royal Hospitals NHS Trust, The Royal London Hospital, London, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
